In a two-part series on Science Speaks, the Center for Global Health Policy recently interviewed scientific leaders at the Bill & Melinda Gates Foundation for their perspectives on key developments in HIV and tuberculosis (TB) in the last year, and what they see coming down the pipeline in the year ahead. Reporter John Donnelly spoke with Stefano Bertozzi, MD, PhD, director of the Gates HIV and tuberculosis programs, and Peter M. Small, MD, senior program officer for TB at the Gates Foundation. Drs. Bertozzi and Small discussed the rapid scale up of medical male circumcision, the Global Fund and the global financial crisis, and the promise of the Gene Xpert, a TB diagnostic machine that can detect TB and drug resistance in 90 minutes, whereas current methods can take up to three months. Check out ScienceSpeaksBlog.org for the full posts.
< Previous Article | Next Article >